£17.65

Cancer Drug Resistance Research Perspectives

Oncology

Price data last checked 15 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

Pricier than usual. £4 more than the 30-day average — we'd wait.

£18 today · 30-day average £14 · all-time low £13

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 76 days · 76 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 76 days • 9 price levels

Days at Price

Current Price

Price Analysis

Most common price: £13 (18 days, 23.7%)

Price range: £13 - £55

Price levels: 9 different prices over 76 days

Description

One of the main causes of failure in the treatment of cancer is the development of drug resistance by the cancer cells.The design of cancer chemotherapy has become increasingly sophisticated, yet there is no cancer treatment that is 100% effective against disseminated cancer. Resistance to treatment with anticancer drugs results from a variety of factors including individual variations in patients and somatic cell genetic differences in tumors, even those from the same tissue of origin. Frequently resistance is intrinsic to the cancer, but as therapy becomes more and more effective, acquired resistance has also become common. The most common reason for acquisition of resistance to a broad range of anticancer drugs is expression of one or more energy-dependent transporters that detect and eject anticancer drugs from cells, but other mechanisms of resistance including insensitivity to drug-induced apoptosis and induction of drug-detoxifying mechanisms probably play an important role in acquired anticancer drug resistance. Studies on mechanisms of cancer drug resistance have yielded important information about how to circumvent this resistance to improve cancer chemotherapy and have implications for pharmacokinetics of many commonly used drugs.This book presents new and important research in this field.

Product Specifications

Format: hardcover
ASIN: 1600215726
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 01 September 2007
Listed Since: 25 September 2007

Barcode

No barcode data available

Cancer Drug Resistance Research Perspectives

Pricier than usual. £4 more than the 30-day average — we'd wait.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance: 1 (Resistance to Targeted Anti-Cancer Therapeutics, 1)

Cancer Drug Design and Discovery

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Cancer Research at the Leading Edge

Cancer and Stem Cells

Cancer Drug Discovery: Science and History

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Pharmaceutical Perspectives of Cancer Therapeutics

New Topics in Cancer Research (Horizons in Cancer Research)

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)

Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies

Natural Products and Cancer Drug Discovery (Cancer Drug Discovery and Development)

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins (Cancer Drug Discovery and Development)

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways: 15

Theranostic Approaches in Nuclear Medicine as a Strategy to Overcome Cancer Treatment Resistance (Novel approaches to overcome cancer resistance to conventional therapies)

Nutraceuticals and Cancer

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)

Systems Biology in Cancer Research and Drug Discovery

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)